The study identifies a genetic risk score to differentiate type 1 and monogenic diabetes in a Chinese population, indicating potential for improved diagnosis.
The authors declare no conflicts of interest. The data of this study are not openly available due to reasons of sensitivity and are available from the corresponding author on reasonable request. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70664. Table S1: Clinical characteristics of participants with type 1 diabetes and monogenic diabetes. Table S2:. Clinical characteristics of participants with monogenic diabetes. Table S3:. Characteristics of four loci associated with T1D risk in the Chinese population. Figure S1:. Genetic risk scores (GRS) for type 1 diabetes (T1D) calculated from four single‑nucleotide polymorphisms (SNPs) in 166 patients with T1D. Data are stratified by age at diagnosis (0–18 years vs. 19–40 years). Figure S2:. Genetic risk scores (GRS) for type 1 diabetes (T1D) calculated from four single‑nucleotide polymorphisms (SNPs) in 166 individuals with T1D. Data are stratified by autoantibody status (antibody‑positive vs. antibody‑negative). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: